$24.05
+0.74 (+3.17%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+42.56%
1Y
+76.58%
YTD
+47.82%
Open$23.90
Previous Close$23.31
Day High$24.34
Day Low$23.65
52W High$24.65
52W Low$12.58
Volume—
Avg Volume2.07M
Market Cap3.70B
P/E Ratio—
EPS$-2.97
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.67
Above
SMA 200
$15.96
Above
RSI (14)
42.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+218.3% upside
Current
$24.05
$24.05
Target
$76.55
$76.55
$56.04
$76.55 avg
$105.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 267.02M | 243.47M | 233.58M |
| Net Income | 59.27M | 48.26M | 42.10M |
| Profit Margin | 22.2% | 19.8% | 18.0% |
| EBITDA | 80.54M | 76.00M | 71.04M |
| Free Cash Flow | 42.58M | 43.55M | 31.33M |
| Rev Growth | -5.4% | -1.1% | +3.4% |
| Debt/Equity | 0.51 | 0.57 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $233.69 | +1.60% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.34 | +0.76% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.84 | +0.78% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $469.49 | +0.58% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.15 | +0.92% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $287.84 | +0.50% | 64.3 | 37.13B |